Cannabis Sativa, Inc. (CBDS)
USD 0.03
(-1.21%)
USD 0.03
(-1.21%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.17 Million USD | -24.69% |
| 2022 | 1.55 Million USD | -15.36% |
| 2021 | 1.84 Million USD | -9.52% |
| 2020 | 2.03 Million USD | 75.5% |
| 2019 | 1.15 Million USD | 129.33% |
| 2018 | 505.7 Thousand USD | 59.03% |
| 2017 | 317.98 Thousand USD | 990.18% |
| 2016 | 29.16 Thousand USD | 151.23% |
| 2015 | 11.61 Thousand USD | 62.35% |
| 2014 | 7151.00 USD | 559.69% |
| 2013 | 1084.00 USD | -99.29% |
| 2012 | 152.37 Thousand USD | -16.89% |
| 2011 | 183.33 Thousand USD | 6.12% |
| 2010 | 172.77 Thousand USD | -5.15% |
| 2009 | 182.16 Thousand USD | -19.62% |
| 2008 | 226.63 Thousand USD | 3.01% |
| 2007 | 220 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 225.13 Thousand USD | -3.81% |
| 2024 Q2 | 234.39 Thousand USD | 4.11% |
| 2023 Q3 | 271.2 Thousand USD | -16.09% |
| 2023 Q4 | 234.05 Thousand USD | -13.7% |
| 2023 Q1 | 345.36 Thousand USD | 16.72% |
| 2023 Q2 | 323.19 Thousand USD | -6.42% |
| 2023 FY | 1.17 Million USD | -24.69% |
| 2022 Q3 | 383.07 Thousand USD | -16.01% |
| 2022 Q2 | 456.08 Thousand USD | 7.64% |
| 2022 FY | 1.55 Million USD | -15.36% |
| 2022 Q4 | 295.88 Thousand USD | -22.76% |
| 2022 Q1 | 423.7 Thousand USD | 8.84% |
| 2021 Q3 | 463.04 Thousand USD | -8.65% |
| 2021 Q4 | 389.27 Thousand USD | -15.93% |
| 2021 Q1 | 557.32 Thousand USD | 54.27% |
| 2021 FY | 1.84 Million USD | -9.52% |
| 2021 Q2 | 506.88 Thousand USD | -9.05% |
| 2020 Q2 | 721.09 Thousand USD | 46.23% |
| 2020 FY | 2.03 Million USD | 75.5% |
| 2020 Q4 | 361.26 Thousand USD | -21.43% |
| 2020 Q3 | 459.78 Thousand USD | -36.24% |
| 2020 Q1 | 493.14 Thousand USD | 8.44% |
| 2019 Q1 | 100.28 Thousand USD | 3.36% |
| 2019 Q2 | 151.06 Thousand USD | 50.64% |
| 2019 Q3 | 453.65 Thousand USD | 200.31% |
| 2019 FY | 1.15 Million USD | 129.33% |
| 2019 Q4 | 454.73 Thousand USD | 0.24% |
| 2018 FY | 505.7 Thousand USD | 59.03% |
| 2018 Q2 | 206.47 Thousand USD | 118.28% |
| 2018 Q3 | 107.61 Thousand USD | -47.88% |
| 2018 Q4 | 97.02 Thousand USD | -9.84% |
| 2018 Q1 | 94.59 Thousand USD | -51.13% |
| 2017 Q3 | 121.4 Thousand USD | 6028.22% |
| 2017 Q2 | 1981.00 USD | 86.01% |
| 2017 FY | 317.98 Thousand USD | 990.18% |
| 2017 Q1 | 1065.00 USD | -78.38% |
| 2017 Q4 | 193.53 Thousand USD | 59.42% |
| 2016 Q3 | 6707.00 USD | -86.78% |
| 2016 Q2 | 50.73 Thousand USD | 236.25% |
| 2016 Q4 | 4925.00 USD | -26.57% |
| 2016 FY | 29.16 Thousand USD | 151.23% |
| 2016 Q1 | 15.08 Thousand USD | 329.34% |
| 2015 Q2 | 617.00 USD | -44.01% |
| 2015 FY | 11.61 Thousand USD | 62.35% |
| 2015 Q4 | 3514.00 USD | -44.9% |
| 2015 Q3 | 6378.00 USD | 933.71% |
| 2015 Q1 | 1102.00 USD | -74.75% |
| 2014 FY | 7151.00 USD | 559.69% |
| 2014 Q3 | 1114.00 USD | 390.75% |
| 2014 Q2 | 227.00 USD | -84.29% |
| 2014 Q4 | 4365.00 USD | 291.83% |
| 2014 Q1 | 1445.00 USD | 105.26% |
| 2013 Q1 | 52.3 Thousand USD | 110.67% |
| 2013 FY | 1084.00 USD | -99.29% |
| 2013 Q3 | 109.00 USD | 0.0% |
| 2013 Q4 | 704.00 USD | 545.87% |
| 2013 Q2 | - USD | -100.0% |
| 2012 Q4 | 24.82 Thousand USD | -2.46% |
| 2012 Q1 | 55.66 Thousand USD | 76.37% |
| 2012 Q2 | 46.43 Thousand USD | -16.58% |
| 2012 Q3 | 25.45 Thousand USD | -45.19% |
| 2012 FY | 152.37 Thousand USD | -16.89% |
| 2011 FY | 183.33 Thousand USD | 6.12% |
| 2011 Q4 | 31.56 Thousand USD | 1.49% |
| 2011 Q2 | 64.72 Thousand USD | 15.69% |
| 2011 Q3 | 31.09 Thousand USD | -51.96% |
| 2011 Q1 | 55.95 Thousand USD | 95.85% |
| 2010 Q2 | 58.69 Thousand USD | 2.17% |
| 2010 Q1 | 57.44 Thousand USD | 99.84% |
| 2010 Q3 | 28.07 Thousand USD | -52.17% |
| 2010 FY | 172.77 Thousand USD | -5.15% |
| 2010 Q4 | 28.56 Thousand USD | 1.77% |
| 2009 FY | 182.16 Thousand USD | -19.62% |
| 2009 Q4 | 28.74 Thousand USD | -9.04% |
| 2009 Q1 | 57.33 Thousand USD | 43.33% |
| 2009 Q2 | 64.48 Thousand USD | 12.48% |
| 2009 Q3 | 31.59 Thousand USD | -51.0% |
| 2008 FY | 226.63 Thousand USD | 3.01% |
| 2008 Q4 | 40 Thousand USD | 0.0% |
| 2008 Q1 | 70 Thousand USD | 0.0% |
| 2008 Q3 | 40 Thousand USD | -42.86% |
| 2008 Q2 | 70 Thousand USD | 0.0% |
| 2007 FY | 220 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Achiko AG | 62.5 Thousand USD | -1777.918% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | 8.52 Million USD | 86.232% |
| CompuMed, Inc. | 5.83 Million USD | 79.894% |
| CompuGroup Medical SE & Co. KGaA | 1.31 Billion USD | 99.91% |
| Cogstate Limited | 43.42 Million USD | 97.297% |
| CareView Communications, Inc. | 9.68 Million USD | 87.879% |
| Craneware plc | 189.26 Million USD | 99.38% |
| Caduceus Software Systems Corp. | 6.58 Million USD | 82.183% |
| Certive Solutions Inc. | 1.27 Million USD | 7.6% |
| Drug Free Solution, Inc. | 805.00 USD | -145717.391% |
| DATATRAK International, Inc. | 6.18 Million USD | 81.019% |
| Strainsforpains, Inc. | 84.11 Thousand USD | -1295.49% |
| Healixa Inc. | 598.88 Thousand USD | -96.003% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | 16.45 Million USD | 92.868% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | 322 Thousand USD | -264.543% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | - USD | -Infinity% |
| IQ-AI Limited | 775.75 Thousand USD | -51.315% |
| Cannabiz Mobile, Inc. | - USD | -Infinity% |
| Mednow Inc. | 12.99 Million USD | 90.968% |
| Galileo Life Sciences, Inc. | - USD | -Infinity% |
| MediXall Group, Inc. | 59.26 Thousand USD | -1880.546% |
| Mitesco, Inc. | - USD | -Infinity% |
| MobileSmith, Inc. | 1.57 Million USD | 25.371% |
| NantHealth, Inc. | 67 Million USD | 98.248% |
| Net Medical Xpress Solutions, Inc. | 597 Thousand USD | -96.621% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | 324.86 Thousand USD | -261.324% |
| Patient Access Solutions, Inc. | 212.73 Thousand USD | -451.778% |
| Pharma-Bio Serv, Inc. | 16.97 Million USD | 93.086% |
| PPJ Healthcare Enterprises, Inc. | 711.03 Thousand USD | -65.087% |
| Medical Cannabis Payment Solutions, Inc. | - USD | -Infinity% |
| Renalytix Plc | 2.28 Million USD | 48.719% |
| Revium Recovery Inc. | - USD | -Infinity% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | 1.46 Million USD | 19.84% |
| Vaso Corporation | 81.02 Million USD | 98.551% |
| Vynleads, Inc. | - USD | -Infinity% |